Literature DB >> 19352693

IL6 genotype and creatine kinase response to exercise.

Jani Lappalainen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19352693     DOI： 10.1007/s00421-009-1053-2

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN： 1439-6319            Impact factor:   3.078


× No keyword cloud information.
  5 in total

1.  Multiplex detection of single-nucleotide variations using molecular beacons.

Authors:  S A Marras; F R Kramer; S Tyagi
Journal:  Genet Anal       Date:  1999-02

2.  Rapid screening for HLA-B27 by a TaqMan-PCR assay using sequence-specific primers and a minor groove binder probe, a novel type of TaqMan trade mark probe.

Authors:  Sylvain Kuzio; Kuzio Sylvain; Aurélie Hanguehard; Hanguehard Aurélie; Marc Morelle; Morelle Marc; Christophe Ronsin; Ronsin Christophe
Journal:  J Immunol Methods       Date:  2004-04       Impact factor: 2.303

3.  A novel NlaIII polymorphism in the human IL-6 promoter.

Authors:  O Olomolaiye; N A Wood; J L Bidwell
Journal:  Eur J Immunogenet       Date:  1998 Apr-Jun

4.  The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.

Authors:  D Fishman; G Faulds; R Jeffery; V Mohamed-Ali; J S Yudkin; S Humphries; P Woo
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

5.  IL6 (-174) and TNFA (-308) promoter polymorphisms are associated with systemic creatine kinase response to eccentric exercise.

Authors:  Chen Yamin; José Alberto Ramos Duarte; José Manuel Fernandes Oliveira; Offer Amir; Moran Sagiv; Nir Eynon; Michael Sagiv; Ruthie E Amir
Journal:  Eur J Appl Physiol       Date:  2008-08-30       Impact factor: 3.078
  5 in total
  1 in total

Review 1.  Genetic variation and exercise-induced muscle damage: implications for athletic performance, injury and ageing.

Authors:  Philipp Baumert; Mark J Lake; Claire E Stewart; Barry Drust; Robert M Erskine
Journal:  Eur J Appl Physiol       Date:  2016-06-13       Impact factor: 3.078
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.